Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Molly, Hoss"'
Publikováno v:
Primary care. 49(4)
During the COVID-19 pandemic, providers and patients explored the use of telehealth on a wide and rapid scale. Reflecting on how prenatal providers and pregnant patients used telehealth during the pandemic and afterward, we review existing and new le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8bfd9920b82794d6e673f9d4f8d95a
https://pubmed.ncbi.nlm.nih.gov/36357065
https://pubmed.ncbi.nlm.nih.gov/36357065
Publikováno v:
American family physician. 104(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d1f08174cfd70978d6f62c8c1259eb0
https://pubmed.ncbi.nlm.nih.gov/34652110
https://pubmed.ncbi.nlm.nih.gov/34652110
Publikováno v:
The Journal of Family Practice. 70
NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitaliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37af7adc62f4c63a510ff41cedd71a21
https://doi.org/10.12788/jfp.0191
https://doi.org/10.12788/jfp.0191
Autor:
Corey Lyon, Molly Hoss
Publikováno v:
Evidence-Based Practice. 23:5-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda7dc18cb5284a0d157aa03fb775284
https://doi.org/10.1097/ebp.0000000000000910
https://doi.org/10.1097/ebp.0000000000000910
Autor:
Molly Hoss
Publikováno v:
Evidence-Based Practice. 23:4-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7936b8a88d347bb69bfbd3905ee96b36
https://doi.org/10.1097/ebp.0000000000000534
https://doi.org/10.1097/ebp.0000000000000534
Autor:
Corey Lyon, Molly Hoss
Publikováno v:
Evidence-Based Practice. 21:4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a05bea0f5a5b5824d36c0a83ceaf0933
https://doi.org/10.1097/01.ebp.0000542002.94731.b5
https://doi.org/10.1097/01.ebp.0000542002.94731.b5
Autor:
Corey Lyon, Molly Hoss
Publikováno v:
Evidence-Based Practice. 20:E12
Review of: Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al; EMPA-REG OUTCOME Investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016; 375(4):323–334.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb64e72ac1809d272d93a8cf00ebe871
https://doi.org/10.1097/01.ebp.0000541808.45899.70
https://doi.org/10.1097/01.ebp.0000541808.45899.70